Literature DB >> 18947509

Augmentation cystoplasty: what are the indications?

Polina Reyblat1, David A Ginsberg.   

Abstract

Augmentation cystoplasty has been studied and performed by urologists for more than 100 years. Although specific indications, techniques, and materials used have undergone major changes and revisions during this period, the general concepts have remained the same. Bladder augmentation increases the bladder's storage capacity. Specific indications include structurally diminished bladder capacity, neurogenically incapacitated bladder, special circumstances of overactive bladder, and interstitial cystitis. This article briefly reviews techniques including laparoscopic and extraperitoneal approaches. Most common long-term consequences of bladder augmentation including chronic infections, bladder stones, perforation, and malignancy are described. Overall, we demonstrate that in appropriately selected patients, bladder augmentation presents an excellent treatment option to improve bladder capacity, achieve socially acceptable continence, and stabilize renal function.

Entities:  

Mesh:

Year:  2008        PMID: 18947509     DOI: 10.1007/s11934-008-0078-0

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  36 in total

1.  Long-term urodynamics followup of bladder augmentation for neurogenic bladder.

Authors:  Marcus L Quek; David A Ginsberg
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

2.  Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.

Authors:  Brigitte Schurch; Marianne de Sèze; Pierre Denys; Emmanuel Chartier-Kastler; Francois Haab; Karel Everaert; Pierre Plante; Brigitte Perrouin-Verbe; Catherine Kumar; Stephanie Fraczek; Mitchell F Brin
Journal:  J Urol       Date:  2005-07       Impact factor: 7.450

Review 3.  Multiple sclerosis and the urologist.

Authors:  S E Litwiller; E M Frohman; P E Zimmern
Journal:  J Urol       Date:  1999-03       Impact factor: 7.450

4.  Surgical and patient reported outcomes of 'clam' augmentation ileocystoplasty in spinal cord injured patients.

Authors:  J Khastgir; R Hamid; M Arya; N Shah; P J R Shah
Journal:  Eur Urol       Date:  2003-03       Impact factor: 20.096

5.  Multiple sclerosis prevalence and possible lead exposure.

Authors:  George Turabelidze; Mario Schootman; Bao-Ping Zhu; Joseph L Malone; Steven Horowitz; Joseph Weidinger; Dhelia Williamson; Eduardo Simoes
Journal:  J Neurol Sci       Date:  2008-02-20       Impact factor: 3.181

Review 6.  Describing bladder storage function: overactive bladder syndrome and detrusor overactivity.

Authors:  Paul Abrams
Journal:  Urology       Date:  2003-11       Impact factor: 2.649

7.  Gastrocystoplasty: long-term followup.

Authors:  Willam DeFoor; Eugene Minevich; Deborah Reeves; Leslie Tackett; Jeffrey Wacksman; Curtis Sheldon
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

8.  Long-term evaluation of metabolic profile and bone mineral density after ileocystoplasty in children.

Authors:  Ashraf T Hafez; Gordon McLorie; David Gilday; Bernd Laudenberg; Jyoti Upadhyay; Darius Bagli; Antoine E Khoury
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

9.  Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.

Authors:  Michael Akbar; Rainer Abel; Thorsten M Seyler; Jens Bedke; Axel Haferkamp; Hans J Gerner; Klaus Möhring
Journal:  BJU Int       Date:  2007-05-26       Impact factor: 5.588

10.  Long-term results of Ingelman-Sundberg denervation procedure for urge incontinence refractory to medical therapy.

Authors:  O Lenaine Westney; Justin T Lee; Edward J McGuire; J Lynn Palmer; R Duane Cespedes; Cindy L Amundsen
Journal:  J Urol       Date:  2002-09       Impact factor: 7.450

View more
  16 in total

Review 1.  Sacral nerve modulation in overactive bladder.

Authors:  John A Occhino; Steven W Siegel
Journal:  Curr Urol Rep       Date:  2010-09       Impact factor: 3.092

Review 2.  Indications for Augmentation Cystoplasty in the Era of OnabotulinumtoxinA.

Authors:  Evan Shreck; Kevin Gioia; Alvaro Lucioni
Journal:  Curr Urol Rep       Date:  2016-04       Impact factor: 3.092

3.  Regenerative medicine strategies for treatment of neurogenic bladder.

Authors:  Roberto Soler; Claudius Fullhase; Anthony Atala
Journal:  Therapy       Date:  2009

Review 4.  Surgical management of the neurogenic bladder after spinal cord injury.

Authors:  Jean-Jacques Wyndaele; Brian Birch; Albert Borau; Frank Burks; David Castro-Diaz; Emmanuel Chartier-Kastler; Marcus Drake; Osamu Ishizuka; Tomonori Minigawa; Eloy Opisso; Kenneth Peters; Barbara Padilla-Fernández; Christine Reus; Noritoshi Sekido
Journal:  World J Urol       Date:  2018-04-21       Impact factor: 4.226

Review 5.  A review of lower urinary tract symptoms in patients with Parkinson's disease.

Authors:  Anand V Badri; Rajveer S Purohit; Jason Skenazy; Jeffrey P Weiss; Jerry G Blaivas
Journal:  Curr Urol Rep       Date:  2014-09       Impact factor: 3.092

6.  Retubularization of the ileocystoplasty patch for conversion into an ileal conduit.

Authors:  Peter A Massaro; Jerzy B Gajewski; Greg Bailly
Journal:  Can Urol Assoc J       Date:  2013 Jul-Aug       Impact factor: 1.862

7.  Regenerative medicine strategies for treating neurogenic bladder.

Authors:  James J Yoo; Jennifer Olson; Anthony Atala; Bupwan Kim
Journal:  Int Neurourol J       Date:  2011-09-30       Impact factor: 2.835

Review 8.  Overactive bladder.

Authors:  Karen M Wallace; Marcus J Drake
Journal:  F1000Res       Date:  2015-12-07

9.  The satisfaction of patients with refractory idiopathic overactive bladder with onabotulinumtoxinA and augmentation cystoplasty.

Authors:  Ahmed S El-Azab; Ahmed M Moeen
Journal:  Arab J Urol       Date:  2013-08-12

Review 10.  Augmentation cystoplasty in neurogenic bladder.

Authors:  Bülent Çetinel; Ervin Kocjancic; Çetin Demirdağ
Journal:  Investig Clin Urol       Date:  2016-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.